Paul Tudor Jones Dice Therapeutics, Inc. Transaction History

Tudor Investment Corp Et Al

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$25.86 - $46.71 $346,317 - $625,540	-13,392 Reduced 45.11%	16,294 $757,000
Q1 2023 May 15, 2023	BUY	$26.05 - $32.31 $773,320 - $959,154	29,686 New	29,686 $851,000
Q2 2022 Aug 15, 2022	BUY	$13.19 - $22.1 $17,147 - $28,730	1,300 Added 11.74%	12,369 $192,000
Q1 2022 May 16, 2022	SELL	$14.54 - $25.02 $18,902 - $32,526	-1,300 Reduced 10.51%	11,069 $212,000
Q4 2021 Feb 14, 2022	SELL	$22.41 - $37.54 $1.6 Million - $2.69 Million	-71,601 Reduced 85.27%	12,369 $313,000
Q3 2021 Nov 15, 2021	BUY	$31.92 - $37.0 $2.68 Million - $3.11 Million	83,970 New	83,970 $2.75 Million

17.7K

13K

Ticker DICE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,430,000
Description
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.